The Patent Finder

AmDerma Pharmaceuticals, LLC

Also on record
Records under this name other than patents AmDerma Pharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to AmDerma Pharmaceuticals, LLC

PatentTitleStatus Expires Confidence
US 9,511,044Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Lapsed on the fee record
Ended Dec 6, 2024 · From the USPTO record
Lapsed on the fee recordEnded Dec 6, 2024From the USPTO record
US 10,632,085Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
Lapsed on the fee record
Ended Apr 28, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 28, 2024From the USPTO record
US 9,301,931Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
Lapsed on the fee record
Ended Apr 5, 2024 · From the USPTO record
Lapsed on the fee recordEnded Apr 5, 2024From the USPTO record
US 8,101,660Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Lapsed on the fee record
Ended Jan 24, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 24, 2024From the USPTO record
US 9,227,928Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts
Lapsed on the fee record
Ended Jan 5, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jan 5, 2024From the USPTO record
US 9,192,592Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
Formerly held
Lapsed on the fee record
Ended Nov 24, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 24, 2023From the USPTO record
US 10,441,530Skin penetration enhancing systems for polar drugs
Lapsed on the fee record
Ended Oct 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 15, 2023From the USPTO record
US 10,434,076Use of 2,5-dihydroxybenzene derivatives for treating dermatitis
Formerly held
Lapsed on the fee record
Ended Oct 8, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 8, 2023From the USPTO record
US 7,968,531Use of 2,5-dihydroxybenzenesulphonic acid in the production of medicaments for the treatment of angiodependent diseases such as cancer and psoriasis
Lapsed on the fee record
Ended Jun 28, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 28, 2023From the USPTO record
US 10,278,940Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
Lapsed on the fee record
Ended May 7, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 7, 2023From the USPTO record
10 of 27 patents shown.
Pro members see all 27.
Pro members: see all 27 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited